Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADO CTCL-3 (Tarado)
DRKS00003693Phase 4Completed
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Dec 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial of bexarotene in cutaneous T-cell lymphoma (CTCL), sponsored by Universitätsklinikum Schleswig-Holstein. Started Dec 2012; status: completed.
02
Drugs
bexarotene
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on DRKS00003693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003693.